This development among Kng1, Bdkrb1, and Bdkrb2 gene expressions, and myofibroblast activators and chronic liver injury creates a new direction in the study of liver fibrosis and its resolution. The gene discussed is BDKRB1; the disease is Hepatic fibrosis.